Hyaluronic acid (HA) and chondroitin sulfate (CS) (HA/CS)

Hyaluronic acid (HA) and chondroitin sulfate (CS) are major glycosaminoglycans (GAGs) that serve as fundamental structural components of the extracellular matrix, particularly within articular cartilage and synovial fluid (PubChem CID 24759, 24766). Hyaluronic acid is a high-molecular-weight, non-sulfated polysaccharide that provides essential viscoelasticity for joint lubrication and shock absorption, while chondroitin sulfate is a sulfated GAG that provides resistance to compression (StatPearls, Viscosupplementation). In degenerative conditions such as osteoarthritis, the concentration and molecular weight of these molecules are significantly reduced, leading to joint pain and functional impairment (NIH, Osteoarthritis). Therapeutically, these molecules are often administered together or individually as viscosupplements to restore joint homeostasis, reduce inflammation, and slow the progression of cartilage breakdown (PubMed, PMID: 29070154). Beyond their mechanical roles, HA and CS interact with cell-surface receptors like CD44 and RHAMM to regulate intracellular signaling pathways involved in cell proliferation, migration, and the inflammatory response (UniProt, P16070). While generally safe, their role in cell signaling necessitates caution in oncological contexts, as they can influence tumor microenvironments and metastasis.

Other names

HyaluronanChondroitin 4-sulfateChondroitin 6-sulfateAcid mucopolysaccharidesGlycosaminoglycansPoly(beta-glucuronic acid-[1->3]-beta-N-acetylglucosamine-[1->4])Galactosaminoglycan

Viscosupplementation to restore synovial fluid elasticity, inhibition of pro-inflammatory cytokines (e.g., IL-1beta), chondroprotection through the stimulation of endogenous glycosaminoglycan synthesis, and modulation of cell signaling via CD44 and RHAMM receptors.